Occipital Transcutaneous Stimulation in Chronic Migraine
Phase 4
- Conditions
- Chronic Migraine
- Interventions
- Device: Cefaly Kit Arnold
- Registration Number
- NCT02307071
- Lead Sponsor
- University of Liege
- Brief Summary
This study evaluates the effect in chronic migraine patients of daily 20 minute-transcutaneous sub occipital neurostimulation using the occipital Cefaly° device.
- Detailed Description
Chronic migraine is a disabling neurological condition affecting 0.5-2% of the population.
CM is difficult to treat and preventive treatment options are limited. Due to the inefficiency of available and the lack of new preventive anti-migraine drug, neurostimulation methods have raised great interest in recent years.
The ONSTIM study showed a reduction in headache frequency in 39% of patients treated with active ONS during 12 weeks, compared to no improvement in the "non-effectively" stimulated or medically treated groups.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- diagnosis of chronic migraine (ICHD III beta 1.3) with or without medication overuse
Exclusion Criteria
- other diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Cefaly Kit Arnold Cefaly Kit Arnold Occipital transcranial stimulation is implemented in occipital region at 16 mA of intensity, for 20 minutes, everyday for 3 months, in 20 chronic migraine patients.
- Primary Outcome Measures
Name Time Method Monthly frequency of migraine days 2 months treatment
- Secondary Outcome Measures
Name Time Method Monthly frequency of headache days 2 months Monthly acute drug intake 2 months Monthly frequency of total headache days 2 months Cumulative monthly headache hours 2 months
Trial Locations
- Locations (1)
CHR Citadelle
🇧🇪Liege, Belgium